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The epidermis is a stratified epithelium providing 
a first line of defense against the harsh external 
environment. The skin also maintains the body’s 
integrity by sequestering the internal milieu and 
impeding transcutaneous water loss through the 
formation of an impermeability barrier. This pro-
tective barrier is conferred by the outermost layer 
of the epidermis, the stratum corneum (SC), 
which results from a finely regulated terminal cell 
differentiation process from the basal layer of the 
epidermis to the granular layers (GRs), through 
the spinous compartment. The SC consists of 
dead and keratin-filled cells, corneocytes, which 
are attached to each other by corneodesmosomes 
and embedded in a lipid matrix (1–3). Proteolytic 
degradation of corneodesmosomes by epidermal 
proteases leads to the shedding of the most super-
ficial corneocytes (4). This desquamation process 
allows the regulation of the skin thickness. Alter-
ations in these processes, as well as mutations in 
genes encoding proteins involved in terminal dif-
ferentiation, can lead to abnormal stratification 
and keratinization, as seen in ichthyoses (5).
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Netherton syndrome (NS) is a severe genetic skin disease with constant atopic manifesta-
tions that is caused by mutations in the serine protease inhibitor Kazal-type 5 (SPINK5) 
gene, which encodes the protease inhibitor lymphoepithelial Kazal-type–related inhibitor 
(LEKTI). Lack of LEKTI causes stratum corneum detachment secondary to epidermal prote-
ases hyperactivity. This skin barrier defect favors allergen absorption and is generally  
regarded as the underlying cause for atopy in NS. We show for the first time that the 
pro-Th2 cytokine thymic stromal lymphopoietin (TSLP), the thymus and activation-regu-
lated chemokine, and the macrophage-derived chemokine are overexpressed in LEKTI-
deficient epidermis. This is part of an original biological cascade in which unregulated 
kallikrein (KLK) 5 directly activates proteinase-activated receptor 2 and induces nuclear 
factor B–mediated overexpression of TSLP, intercellular adhesion molecule 1, tumor 
necrosis factor , and IL8. This proinflammatory and proallergic pathway is independent of 
the primary epithelial failure and is activated under basal conditions in NS keratinocytes. 
This cell-autonomous process is already established in the epidermis of Spink5/ embryos, 
and the resulting proinflammatory microenvironment leads to eosinophilic and mast cell 
infiltration in a skin graft model in nude mice. Collectively, these data establish that un-
controlled KLK5 activity in NS epidermis can trigger atopic dermatitis (AD)–like lesions, 
independently of the environment and the adaptive immune system. They illustrate the 
crucial role of protease signaling in skin inflammation and point to new therapeutic targets 
for NS as well as candidate genes for AD and atopy.
© 2009 Briot et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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postnatal mortality, and are probably favored by the severe 
alteration of the skin barrier function.
We previously identified serine protease inhibitor Kazal-type 
5 (SPINK5) as the defective gene in NS (26). SPINK5 en-
codes the multidomain serine protease inhibitor lymphoepi-
thelial Kazal-type–related inhibitor (LEKTI), whose tissue 
distribution pattern is restricted to the most differentiated via-
ble layers of stratified epithelial tissues and the Hassall’s cor-
puscles in the thymus (27). In the epidermis, LEKTI is mainly 
restricted to the GR. It is expressed as high molecular mass 
precursors, which are rapidly processed into several proteolytic 
fragments secreted in the intercellular space (27, 28). It has 
been shown that LEKTI fragments can efficiently and specifi-
cally inhibit the epidermal kallikrein (KLK) 5, KLK7, and 
KLK14 (28–30).
Using Spink5 KO mice (Spink5/), which faithfully repro-
duce key features of NS (31–33), we deciphered the biological 
functions of LEKTI and identified cutaneous pathophysiologi-
cal pathways of the disease. We showed that epidermal LEKTI 
deficiency results in KLK5 and KLK7 hyperactivity and dys-
regulation of a new epidermal protease, which is under charac-
terization. These unrestricted protease activities lead to abnormal 
desmosome cleavage in the upper GR, resulting in accelerated 
SC shedding and consequent loss of skin barrier function. This 
work identified LEKTI as a key regulator of epidermal protease 
activity and skin barrier integrity (32).
Because NS patients suffer from severe atopic manifesta-
tions, such as AD, genetic association between SPINK5 single 
nucleotide polymorphisms and severe AD has been tested by 
several groups (34–41). Positive association was found in sev-
eral studies in patients with different ethnical background (34, 
36). Although the skin barrier defect is considered to be the 
key event leading to skin inflammation and allergy (42), it is 
likely that more specific and intrinsic signals could be directly 
induced by SPINK5/ keratinocytes. In this paper, we there-
fore explored the molecular mechanisms leading to the re-
cruitment of inflammatory cells in NS skin. We show that in 
LEKTI-deficient keratinocytes, KLK5 hyperactivity activates 
proinflammatory signaling, leading to the recruitment of eo-
sinophilic and mast cells, which is reminiscent of AD-like skin 
lesions in NS, independent from skin barrier defect, environ-
mental stimuli, and the adaptive immune system.
RESULTS
Spink5/ grafted skin reproduces the histological  
and ultrastructural anomalies of NS
As newborn Spink5/ (KO) mice died a few hours after birth 
(32), total dorsal skin of embryonic day (E) 19.5 embryos was 
grafted on nude mice to analyze the consequences of Spink5 
inactivation in adult skin. 8 wk after grafting, WT skin (WTg) 
presented normal hair development (Fig. 1 A), whereas the 
KO graft was alopecic, scaly, and erythematous (Fig. 1 B). 
Histological analysis showed that WT grafted skin was similar 
to adult WT skin (Fig. 1 C). In contrast, the KO epidermis 
was hyperplastic (acanthosis), with epidermal invaginations in 
the dermis (papillomatosis), and nuclei were seen to persist in 
In this respect, the filament-aggregating protein FILAG-
GRIN is a key protein that plays an important role in the for-
mation of the barrier function. Recent genetic studies have 
shown that loss-of-function mutations in the gene encoding 
FILAGGRIN underlie ichthyosis vulgaris (6), a very common 
genetic disorder of keratinization. The same FILAGGRIN 
mutations have also been identified as a major risk factor for 
atopic dermatitis (AD) and are strongly associated with asthma 
in AD patients (7, 8). These results linked for the first time a 
primary skin disease to systemic allergic manifestations, through 
defective skin barrier function.
AD is a chronic inflammatory skin disease characterized by 
eczema, pruritus, and cutaneous hyperreactivity to environ-
mental factors that are innocuous to normal nonatopic indi-
viduals (9). AD has a complex etiology that results from 
interactions between environment and several susceptibility 
genes involved in skin barrier function and systemic and local 
immunological responses (10, 11). AD is often the initial step 
in the so-called “atopic march,” which leads to asthma and al-
lergic  rhinitis  in  the  majority  of  afflicted  patients  (12–14). 
These conditions are all characterized by elevated serum IgE 
levels  and  peripheral  eosinophilia  (9).  Clinically  unaffected 
skin in AD manifests impaired skin barrier function that could 
favor the penetration of microbes and allergens (15), leading to 
the development of cutaneous and systemic allergies through 
activation of antigen-presenting cells such as Langerhans cells 
(LCs) (16). However, keratinocytes are immunologically ac-
tive cells. Indeed, traumatic barrier disruption alone stimulates 
both keratinocyte proliferation and their cytokine and chemo-
kine production (IL-1, IL-1, TNF-, and GM-CSF), char-
acteristic features of skin inflammatory diseases (17, 18). Thus, 
the skin should be considered as an important organ of innate 
immunity. In fact, keratinocytes from lesional skin of AD 
patients express a proallergic cytokine, thymic stromal lympho-
poietin (TSLP). Notably, the local increase of TSLP is directly 
associated with LC activation and migration to skin draining 
lymph node, where they trigger the differentiation of naive 
CD4+ T cells into proallergic CD4+ Th2 cells (19, 20). TSLP 
overexpression is also sufficient in mouse skin to induce an in-
flammatory Th2 microenvironment and an AD-like skin phe-
notype (21). Keratinocytes are therefore important orchestrators 
of the innate immunity through the secretion of a wide range of 
proinflammatory and proallergic molecules inducing and sup-
porting cutaneous acute and chronic inflammatory responses.
One of the most severe ichthyoses of children and young 
adults is Netherton syndrome (NS; Online Mendelian Inher-
itance of Man reference number 256500). NS is a rare (1 in 
100,000 newborns) autosomal recessive skin disorder charac-
terized  by  generalized  exfoliative  erythroderma,  a  specific 
hair shaft defect (trichorrhexis invaginata) and severe atopic 
manifestations, which distinguish NS from the other ichthy-
oses (22, 23). Indeed, NS patients suffer from recurrent AD 
with elevated serum IgE levels, asthma, and multiple food al-
lergies (24, 25). Bacterial infection, hypernatraemic dehydra-
tion, hypothermia, and extreme weight loss are frequent 
complications during the neonatal period, resulting in high JEM VOL. 206, May 11, 2009 
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the SC (parakeratosis), which appeared focally detached from 
the GR. In addition, a massive inflammatory infiltrate was 
observed  in  the  dermis  and  the  epidermis  associated  with 
spongiosis in the basal layers (Fig. 1 D). The hair follicles were 
hyperplastic and cystic in KO graft, concordant with the alo-
pecic phenotype (Fig. 1, B and D). Analysis of the differentia-
tion program revealed that keratin 14 was only expressed in the 
basal layer of the WT graft epidermis, whereas all layers were 
stained in the KO epidermis (Fig. 1, E and F; and Fig. S5). 
Keratin 10 and involucrin, which are normally expressed in the 
suprabasal and GR of WT epidermis, respectively, extended to 
more profound spinous layers in the KO graft (Fig. 1, G–J; and 
Fig. S5). We previously demonstrated in newborn KO mice 
that premature desmosome cleavage leading to SC detach-
ment was a key event of NS (32). As SC cohesion was also af-
fected in KO graft, desmosomes were examined by electron 
microscopy. Well-structured desmosomes were seen at the 
interface between the GR and the SC (GR-SC) of the WT 
grafted epidermis, whereas asymmetrical split of desmosomes 
was observed in KO graft resulting in the loss of GR-SC co-
hesion and increase of intercellular space (Fig. 1, M and N). The 
desmosomal cadherin desmoglein-1 was not detected in these 
superficial layers of the KO epidermis (Fig. 1 L and Fig. S5), 
which is in agreement with its degradation as previously de-
scribed in newborn KO mice and NS skin (32, 43). In sum-
mary, the abnormal differentiation pattern observed in KO 
graft, together with the desmosomal cleavage, confirmed that 
the KO grafted skin reproduces all major histological and ul-
trastructural anomalies seen in NS patients skin (43), thus pro-
viding a suitable model to understand the long-term effect of 
LEKTI deficiency in the skin.
Spink5/ grafted skin shows a marked inflammatory infiltrate
Skin inflammation is one of the major features of NS, and 
Spink5/ skin grafts exhibited a strong inflammatory infil-
trate. Polynuclear eosinophils were observed in the upper der-
mis and in the basal epidermal layer in KO skin graft (Fig. 2, 
A–C). Eosinophilic cells were six times more numerous in 
KO than in WT dermis (Fig. S1). Toluidine blue coloration 
revealed the presence of a high number of mast cells in the 
dermis of KO graft (fourfold increase) compared with WT 
(Fig. 2, D–F; and Fig. S1). Immunodetection of 1-tryptase 
Figure 1.  Ichthyosiform phenotype, abnormal differentiation, and 
asymmetrical desmosomal split in Spink5/ grafted epidermis.  
(A and B) Macroscopic observation of WT (WTg) or Spink5 KO (KOg) mice 
skin 8 wk after grafting on nude recipient mice. (C and D) Hematoxylin/
eosin staining of skin graft cross sections. The KOg epidermis shows hyper-
plasia with papillomatosis (bracket) and spongiosis, nuclei are seen in cor-
neocytes (parakeratosis; arrow), and an inflammatory infiltrate is present in 
the dermis (asterisks). Pictures are representative of 14 WT and 17 KO inde-
pendent grafts on nude mice, performed in five independent graft series. 
(E–J) Immunohistochemistry of epidermal differentiation markers per-
formed on WTg and KOg grafted skin. (K and L) Desmoglein-1, detected by 
immunohistochemistry in the whole epidermis of WTg, is markedly de-
creased in the GR of KOg epidermis. (M and N) Desmosomes analyzed by 
transmission electron microscopy in the GR-SC intercellular space (red 
arrows). Asymmetrical split desmosomes were observed in KOg epidermis. 
Pictures are representative of two independent experiments, each including 
three WTg and three KOg. HF, hair follicle. Bars: (C and D) 29.4 µm;  
(E–L) 23.5 µm; (M and N) 0.1 µm.
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and active forms (17 kD) of IL-1, which were detected in 
the KO sample only (Fig. 3 C).
Several studies have identified the proteinase-activated re-
ceptor 2 (PAR2) as a major effector of the cutaneous inflamma-
tory response through its proteolytic activation by serine 
proteases (44–46). PAR2 is expressed in keratinocytes, and we 
therefore investigated its possible role in the development of the 
KO graft phenotype by immunohistochemistry analysis. In WT 
epidermis, PAR2 was restricted to the GR, whereas PAR2 
staining was enhanced in the GR and extended to the supra-
basal and basal layers in KO grafted epidermis (Fig. 3, D and E; 
and Fig. S5). The intercellular adhesion molecule 1 (ICAM1), 
which has been described as a direct target gene of PAR2 acti-
vation (47), was restricted to basal cells in the WT epidermis. In 
the KO grafted epidermis, ICAM1 plasma membrane staining 
was observed from the basal to the GR (Fig. 3, F and G; and 
Fig. S5), suggesting PAR2 activation. Increased expression of 
ICAM1 in KO grafted skin was confirmed by Western blot 
analysis (Fig. 3 H).
showed that this proinflammatory protease was detected in 
mast cells in the dermis as well as in the basal and suprabasal 
layers of the KOg epidermis (Fig. 2 H and Fig. S5). Western 
blot analysis confirmed overproduction of 34-kD 1-tryptase 
monomer in KO grafted skin relative to WT (Fig. 2 I). In 
addition to the protease hyperactivities at 20 and 30 kD, 
which has been previously described in embryos (32), casein 
gel zymography experiments showed a KO graft-specific ac-
tivity migrating at 34 kD. This activity was inhibited by leu-
peptin,  which  is  consistent  with  monomeric  1-tryptase 
activity (Fig. S2, B and C). Collectively, these results support 
mast  cells  activation  and  secretion  of  1-tryptase  in  KO 
grafted skin contrary to WT. Our results show that KO 
grafted skin exhibits a massive skin inflammation in athymic 
nude recipient mice, providing evidence that lack of LEKTI 
in the epidermis alone is sufficient to induce cutaneous in-
flammation in the absence of mature T lymphocytes.
Spink5/ grafted epidermis overexpresses  
proinflammatory mediators
The proinflammatory cytokine IL-1 is known to be se-
creted by keratinocytes after SC cohesion disruption (18). 
IL-1 immunostaining was scant and localized at the GR-SC 
interface in WT epidermal grafts. In the KO epidermis, IL-1 
staining was increased and extended to the basal and su-
prabasal layers (Fig. 3, A and B; and Fig. S5). Western blot 
analysis confirmed overexpression of the precursor (31 kD) 
Figure 2.  Inflammatory cells infiltrate in Spink5/ grafted skin. 
(A–C) Hematoxylin/eosin (HE) staining shows a high number of poly-
nuclear eosinophilic cells (yellow arrows) in the upper dermis and the 
basal layer of KO grafted epidermis (KOg). (D–F) Numerous mast cells are 
colored by Toluidine blue (TB) in KOg dermis (black arrows) contrary to 
WTg dermis. (G–I) Immunohistochemistry staining and Western blotting 
confirms increased production of the 34-kD 1-tryptase monomer in KOg 
compared with WTg. Three independent stainings were performed on four 
WTg and four KOg. Western blotting is representative of two independent 
experiments, each including two WTg and two KOg. C and F are enlarge-
ments of B and E, respectively. Bars: (A and B) 9.4 µm; (C) 2 µm;  
(D and E) 11.75 µm; (F) 2.5 µm; (G and H) 23.5 µm.
Figure 3.  Proinflammatory mediators in Spink5/ graft.  
(A and B) IL-1 immunohistochemistry staining is increased in Spink5/ 
grafted epidermis (KOg) compared with WTg. (C) Western blotting reveals the 
presence of high amounts of the proform (31 kD) and active form (17 kD) of 
IL-1 in KOg epidermis. (D–J) Immunohistochemistry experiments on skin 
graft cross sections. (D and E) In WTg epidermis, PAR2 is localized in the GR. 
In KOg, PAR2 staining is increased in the GR and is extended to the basal 
layer. (F and G) ICAM1 is restricted to the basal cells in the WTg epidermis, 
whereas in the KOg it is extended to the membrane of suprabasal and GR 
cells. (H) Western blotting confirms the increase of ICAM1 expression in KOg 
epidermis. (I and J) TSLP is expressed in all epidermal layers of KOg but is not 
detected in WTg epidermis. Immunostaining panels and Western blotting are 
representative of two independent experiments, each including three WTg 
and three KOg, and two WTg and two KOg, respectively. Bars: (A, B, and D–G) 
11.5 µm; (I and J) 23 µm.JEM VOL. 206, May 11, 2009 
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WT, whereas no variation was detected between WT and KO 
dermis (Fig. 4 M).
ICAM1 immunolocalization was restricted to the membrane 
of basal keratinocytes in WT epidermis, whereas in KO epider-
mis the protein was also expressed at the cell surface of suprabasal 
keratinocytes (Fig. 4, G–I; and Fig. S5). Increased immunostain-
ing was also observed in the dermis of KO mice. These results 
were in accordance with the RT-PCR experiments showing 
Icam1 mRNA overexpression in the epidermis and in the dermis 
of KO embryos (Fig. 4 M). ICAM1 overproduction in KO epi-
dermis was confirmed by Western blotting analysis (Fig. S3).
Recently, the major role of the epithelial cell–derived 
cytokine TSLP was highlighted in the induction of cutane-
ous allergic inflammation and in AD epidermis (19), a key 
feature of NS. We therefore analyzed the expression of this 
cytokine in the epidermis of grafted skin. TSLP was not de-
tected in WT grafted epidermis, whereas it was highly ex-
pressed by KO keratinocytes throughout the entire epidermis 
(Fig. 3, I and J; and Fig. S5). Positive cells in the dermis of 
WTg and KOg skin could be unspecific but could also cor-
respond to activated mast cells that are known to express 
the TSLP receptor (Fig. 2, B and C; and Figs. S1 and S5). 
These results illustrated that LEKTI-deficient keratinocytes, 
through the production of proinflammatory mediators and 
TSLP expression, play a central role in the activation of 
innate immunity.
Spink5/ mice epidermis at E19.5 exhibits early 
proinflammatory signals
To investigate whether the inflammation in KO adult skin 
was the result of an intrinsic property of Spink5/ epidermis 
and not secondary to environmental stimuli resulting from a 
skin barrier defect, we analyzed skin from KO mice at E19.5. 
Histological analysis of E19.5 KO skin cross section did not 
reveal any epidermal infiltrate of eosinophilic cells (not de-
picted), nor did it reveal 1-tryptase activity in KO embryo 
(Fig. S2 B), thus excluding the presence of activated mast 
cells at this stage of development.
IL-1 immunostaining was faint and diffuse in the supe-
rior layers of the WT epidermis (Fig. 4 A and Fig. S5). In the 
KO epidermis, the staining was more intense and sharp in the 
area of SC detachment (Fig. 4, B and C; and Fig. S5). RT-
PCR analysis confirmed that Il-1 mRNA expression was 
highly enhanced in the epidermis and the dermis of KO em-
bryos compared with WT (Fig. 4 M).
In addition, we investigated the induction of the proinflam-
matory cytokine TNF-, which is also produced in response to 
cutaneous barrier disruption (17) and tightly associated with in-
flammatory deviation of the immune response, such as asthma 
and probably allergic inflammation (48, 49). Despite unsuccess-
ful immunostaining of TNF- on skin cross sections, we ana-
lyzed its transcriptional expression and showed that Tnf- 
mRNA was strongly overexpressed in the KO epidermis and 
also slightly induced in the dermis of KO embryos compared 
with WT (Fig. 4 M).
To assess whether the PAR2 signaling pathway was acti-
vated at this stage of development, expression and localization of 
the receptor and the product of its target gene ICAM1 were 
studied by immunohistochemistry and RT-PCR analysis. 
PAR2 was detected in suprabasal layers of WT epidermis (Fig. 4 
D and Fig. S5). In KO epidermis, PAR2 staining was increased 
and juxtanuclear. This subcellular localization is consistent with 
the presence of intracytoplasmic vesicles and/or Golgi pool–
containing PAR2 because of its internalization and/or neosyn-
thesis after its activation by epidermal proteases (50) (Fig. 4,   
E and F; and Fig. S5). RT-PCR analysis showed that Par2 mRNA   
was  slightly  overexpressed  in  KO  epidermis  compared  with 
Figure 4.  Early inflammatory events in Spink5/ embryos.  
(A–L) Immunohistochemistry on E19.5 embryos skin cross sections.  
(A–C) IL-1 immunostaining is more intense and sharp in the GR of 
Spink5 KO embryo epidermis (KOe) compared with WT embryo (WTe).  
(D–F) Compared with WTe, PAR2 staining in KOe is increased and juxta-
nuclear in suprabasal keratinocytes. (G–I) In WTe, ICAM1 is restricted to 
the basal keratinocytes and to the dermis, whereas it is extended to su-
prabasal layers in KOe epidermis. (J–L) Contrary to WTe, TSLP staining is 
detected in the suprabasal and GR of KOe epidermis. Immunostaining 
panels are representative of two independent experiments, each including 
three WTe and three KOe. (M) mRNA expression level of Il-1, Tnf-, Par2, 
Icam1, Tslp, Tarc, Mdc, and Hprt were measured by quantitative RT-PCR 
from WTe and KOe epidermis and dermis. Data are representative of two 
independent experiments in which two WTe and two KOe were analyzed. 
C, F, I, and L are enlargements of B, E, H, and K, respectively. Bars:  
(A, B, D, E, G, H, J, and K) 11.5 µm; (C, F, I, and L) 4.9 µm.1140 KLK5 MEDIATES AD VIA EPIDERMAL TSLP EXPRESSION IN NS | Briot et al.
Th2 cytokine TSLP and chemokines TARC and MDC, which 
we showed to be overexpressed in LEKTI-deficient epidermis, 
could be directly up-regulated by hyperactive KLK5.
Addition of recombinant human KLK5 in the conditioned 
medium of normal human primary keratinocytes (NHKs) led 
to an increase of ICAM1 mRNA (mean of fivefold; Fig. 6 A), 
in  accordance  with  previously  published  data,  on  NHK 
treated with trypsin (47), suggesting PAR2 cleavage and acti-
vation  by  KLK5  in  our  in  vitro  model.  In  KLK5-treated 
NHK, TSLP mRNA was significantly increased (mean of 
sevenfold; Fig. 6 A). TSLP overexpression was confirmed by 
immunocytofluorescence detection after KLK5 treatment and 
protein secretion blocking with brefeldin A (Fig. S4). Tran-
scripts  of  the  proinflammatory  molecules  IL8  and  TNF- 
were increased as well, in contrast to IL-1, TARC, and MDC 
expression, which was not induced by KLK5 (Fig. 6 A). These 
data emphasized the role of KLK5 in cutaneous inflammation 
by regulating cytokine and chemokine expression in kerati-
nocytes independently of environmental stimuli, inflamma-
tory cells, and skin barrier defect.
To demonstrate a direct role of PAR2 signaling in up-reg-
ulation of these molecules, we knocked down PAR2 mRNA 
Finally, TSLP was highly expressed in the KO embryonic 
epidermis compared with WT (Fig. 4, J–L; and Fig. S5). TSLP 
immunolocalization appeared to be cytoplasmic and extracel-
lular, suggesting that it was secreted by KO keratinocytes. 
mRNA analysis confirmed the absence of Tslp transcripts in 
WT skin and a marked overexpression in the epidermis of 
E19.5 KO mice (Fig. 4 M).
We also analyzed the expression of two pro-Th2 chemo-
kines,  thymus  and  activation-regulated  chemokine  (Tarc;  Ccl17), 
which was found to be up-regulated in Tslp-transgenic mice 
skin (21), and macrophage-derived chemokine (Mdc; Ccl22). These 
two chemokines are known to preferentially attract CCR4+ 
Th2 cell (51). In the epidermis and the dermis of E19.5 KO 
mice, Tarc and Mdc were overexpressed at the transcriptional 
level (Fig. 4 M).
These results established that proinflammatory and Th2-
polarizing mediators were overexpressed as early as E19.5 in 
the KO epidermis and could be secondary to PAR2 activa-
tion. These in utero events appear to be essential in explain-
ing the inflammatory changes observed in the adult KO skin. 
These observations in Spink5/ embryos support the notion 
that LEKTI-deficient epidermis has the intrinsic property of 
inducing a proinflammatory cascade, even in the absence of 
immune cell infiltrate and environmental stimuli.
The pro-Th2 cytokine TSLP is overexpressed in the skin  
of NS patients
TSLP immunodetection on skin cross sections from two 
healthy controls (healthy 1 and 2) and four NS patients (NS1–
NS4) revealed that the pro-Th2 cytokine was overexpressed in 
the patient skin, in accordance with the result obtained in 
Spink5/ mice epidermis (Fig. 5). In healthy control skin, no 
signal was detected in the epidermis (healthy 1 and 2). In NS 
patient epidermis, a cytoplasmic gradient of TSLP staining was 
observed from the granular to the spinous layer, the intensity of 
which was different between individuals (Fig. 5). Some 
patients also exhibited a dermal staining (NS1 and NS3) that 
could correspond to immune cell infiltrates (Fig. 5), possibly 
mast cells, or to unspecific staining of dermal structures as ob-
served in mouse isotype control panel (Fig. S6 A). These results 
confirmed TSLP overproduction in LEKTI-deficient human 
skin and showed additional similarity with AD skin that could 
account for the recurrent atopic manifestations in NS.
KLK5 up-regulates TSLP and proinflammatory mediator 
expression through PAR2 and NF-B signaling  
in human keratinocytes
We next hypothesized that protease hyperactivity could lead 
to  overexpression  of  proinflammatory  mediators.  Indeed, 
KLK5, but not KLK7, has previously been shown to cleave 
and activate PAR2 (52). Therefore, the unregulated KLK5 
observed in NS and in Spink5/ mice could induce a proin-
flammatory cascade independently of external stimuli.
We analyzed two target genes of PAR2 activation in 
cultured keratinocytes, ICAM1 (47) and the chemokine IL8 (53). 
In addition, we assessed whether IL-1, TNF-, and the pro-
Figure 5.  Overexpression of TSLP in skin of NS patients. Immuno-
fluorescence experiments performed on skin cryosections using anti-TSLP 
antibody (green). TSLP expression is not detectable in two healthy control 
skins but, in contrast, this cytokine is strongly expressed in the skin of 
four NS patients (NS1–NS4). The signal is cytoplasmic in the granular 
keratinocytes and decreases through the spinous layers. The pictures are 
representative of two independent experiments in which two healthy and 
four NS patients were included. Dashed white lines represent epidermis/
dermis junction. Blue staining (DAPI) indicates nuclei. Bars, 11.5 µm.JEM VOL. 206, May 11, 2009 
ARTICLE
1141
(47). Moreover, this treatment also strongly reduced KLK5 
efficiency in inducing TSLP, IL8, and TNF- transcription 
(mean of 81, 59, and 40% decrease, respectively; Fig. 6 C). 
Collectively, these in vitro experiments showed that KLK5 
can directly induce cutaneous inflammation through PAR2 
and NF-B pathway activation, leading to up-regulation of 
TSLP, IL8, and TNF- mRNAs.
KLK5 hyperactivity induces TSLP overexpression  
in keratinocytes from NS patients
Positive staining of TSLP in NS skin (Fig. 5), together with in 
vitro data, supports the hypothesis that, in LEKTI-deficient ke-
ratinocytes, unregulated proteases can directly induce cytokine 
and chemokine secretion, including TSLP. To rule out indirect 
effects of epidermal barrier dysfunction and immune cells on 
TSLP expression, keratinocytes from three different NS patients 
(NSK) were cultivated under the same experimental conditions 
as NHK from three different healthy controls. TSLP mRNA 
quantification revealed that expression of this cytokine was sig-
nificantly enhanced in NSK compared with NHK in baseline 
conditions in vitro (mean of fivefold; Fig. 7 A). ICAM1, IL8, 
and TNF- mRNAs were also increased in NSK in compari-
son to NHK, although no variation was observed for IL-1 
(Fig. 7 A). Expression of TARC and MDC mRNAs was also 
enhanced in NSK compared with NHK (Fig. 7 A), even though 
these two genes encoding chemokines may not be direct target 
genes in the KLK5–PAR2 pathway (Fig. 6 A).
Except for TSLP, the other proinflammatory and pro-
Th2 molecules were overexpressed in two out of three NSK 
compared with NHK (Fig. 7 A). This could reflect interindi-
vidual variations caused by multiple transcriptional regulations 
in a LEKTI-deficient context.
Immunofluorescence  experiments  on  keratinocytes 
treated with brefeldin A confirmed that TSLP was produced 
at high level in NSK compared with NHK (Fig. 7 B). All 
these results confirm that production of TSLP arise from an 
intrinsic property of SPINK5/ cells.
To confirm that unregulated KLK5 secreted by keratino-
cytes could be directly responsible for TSLP and proinflam-
matory molecule overexpression, NSKs were transfected with 
siRNA against KLK5. Down-expression of KLK5 mRNA 
and decreased synthesis of the protein were verified by quan-
titative RT-PCR in NSK (Fig. 7 C) and Western blot analysis 
on the conditioned medium and were quantified by ELISA 
assay (Fig. 7 D). The amount of the protease in the condi-
tioned medium of NSK transfected with KLK5 siRNA was 
significantly decreased compared with control siRNA at 48 h 
(26 vs. 46 pg/µl) and 72 h (118 vs. 382 pg/µl). Concomi-
tantly, TSLP expression was reduced by 42 and 54% at 48 and 
72  h  after  transfection,  respectively  (Fig.  7  E).  However, 
down-regulation of KLK5 in NSK was associated with a less 
efficient decrease of IL8 and TNF- mRNAs and had little 
effect on ICAM1 mRNA expression (Fig. 7 E). The residual 
amount of TSLP mRNA and the weak effect on ICAM1, 
IL8, and TNF- transcripts observed in NSK transfected with 
KLK5 siRNA could be the result of uncompleted knockdown 
using siRNA in NHK and applied a KLK5 on these cells. The 
PAR2 mRNA knockdown was confirmed by quantitative 
RT-PCR (56% decreased; Fig. 6 B). In these conditions, 
ICAM1 stimulation by KLK5 was significantly reduced (mean 
of 55% induction relative to control siRNA), confirming that 
the signaling pathway initiated by PAR2 cleavage was affected 
(Fig. 6 B). KLK5 was also considerably less efficient in induc-
ing TSLP mRNA expression (mean of 48% induction relative 
to control siRNA) as well as IL8 and TNF- transcripts. Pre-
vious studies have shown that up-regulation of ICAM1 by 
PAR2 signaling was mediated by NF-B pathway (47). More-
over, a functional NF-B binding site was previously identi-
fied in the TSLP promoter in airway epithelial cells (54, 55). 
We therefore assessed the involvement of NF-B signaling in 
TSLP, IL8, and TNF- up-regulation by KLK5 using BAY11-
7082, a specific inhibitor of the NF-B pathway. Pretreat-
ment  of  NHK  with  BAY11-7082  decreased  the  effect  of 
KLK5 on ICAM1 mRNA expression (mean of 70% decreased; 
Fig. 6 C), which is in accordance with already published data 
Figure 6.  KLK5 up-regulates TSLP and proinflammatory molecules in 
keratinocytes. (A) NHKs were stimulated with 400 nM of recombinant KLK5 
for 3 h. TSLP, ICAM1, IL8, and TNF- transcripts are increased by seven-, five-, 
four-, and fivefold, respectively. No difference was observed for IL-1,  
TARC, and MDC (n = 5). (B) NHK transfected with 60 pmol PAR2 siRNA and 
stimulated with KLK5 showed PAR2 mRNA down-regulation (by 56%) 4 d 
after transfection. In PAR2 siRNA-transfected cells, KLK5 is less efficient in 
inducing TSLP, ICAM1, IL8, and TNF- mRNA (48, 55, 60, and 62% of control, 
respectively; n = 4). (C) In cells treated with 10 µM NF-B pathway inhibitor 
(BAY11-7082), KLK5 efficiency to up-regulate TSLP, ICAM1, IL8, and TNF- 
mRNA is decreased by 81, 70, 59, and 40%, respectively (n = 3). For each 
experiment, the mRNAs of interest were measured by quantitative RT-PCR. 
Each point is the mean of triplicate amplification for at least three indepen-
dent experiments (n). *, P < 0.05; **, P < 0.01; ***, P < 0.001.1142 KLK5 MEDIATES AD VIA EPIDERMAL TSLP EXPRESSION IN NS | Briot et al.
These results highlight for the first time KLK5’s direct role in 
TSLP up-regulation in NSK, which is independent of external 
stimuli including environment, microorganism penetration, or 
immune cell activation. KLK5 also induced the production of 
other inflammatory molecules that probably maintain and aggra-
vate the proinflammatory microenvironment in the affected skin 
and favor a pro-Th2 microenvironment.
DISCUSSION
The recurrent atopic manifestations, which are constantly as-
sociated with NS, are generally regarded as resulting from pre-
mature SC detachment facilitating allergen penetration and 
inducing stress signal on keratinocytes. In this paper, we pro-
vide evidence that the epidermis plays a major and direct role 
in the modulation of the immune response. We show that in 
baseline culture conditions, keratinocytes from NS patients se-
crete major proinflammatory (ICAM1, IL8, and TNF-) and 
Th2-polarizing (TSLP, TARC, and MDC) mediators in the 
absence of any external stimulation, thus excluding any effect 
of skin barrier disruption and/or pathogen and allergen pene-
tration. We demonstrate for the first time the direct role of 
KLK5 hyperactivity in initiating a proallergic signaling cascade 
through PAR2 receptor cleavage and NF-B pathway activa-
tion, which results in ICAM1, IL8, TNF-, and TSLP over-
expression in keratinocytes (Fig. 8). This study disclosed a new 
role for KLK5 in skin inflammation and in the induction of   
allergic inflammatory actors. Therefore, KLK5 represents a 
major epidermal specific protagonist, which initiates TSLP 
overexpression without contribution of the adaptive immune 
system. In addition, the pro-Th2 mediators TARC and MDC 
were overexpressed in keratinocytes from NS patients inde-
pendently of KLK5 and PAR2 activation. This up-regulation 
could be promoted by other uncontrolled proteases, such as 
KLK7 or KLK14 and/or secreted factors in the medium, sus-
taining the induction of multiple signaling pathways in LEKTI-
deficient skin. These results provide evidence that the activation 
of this biological cascade leading to cutaneous inflammation in 
NS is an intrinsic property of LEKTI-deficient keratinocytes, 
i.e., is a cell-autonomous process.
Analysis of Spink5 KO epidermis in E19.5 embryos re-
vealed that this KLK5 biological cascade is an early event and, 
consequently, is relevant in vivo. In Spink5/ skin, no inflam-
matory infiltrate could be observed in WT and KO epidermis, 
whereas the proinflammatory (Icam1, Il-1, and Tnf-) and 
pro-Th2 (Tslp, Mdc, and Tarc) molecules were already over-
produced (Fig. 4). In addition, these molecules were induced 
in embryos that had been delivered by caesarian from gestate 
females maintained in a pathogen-free environment. That sup-
ports a major and direct role of KO keratinocytes in sensing 
and promoting inflammatory signal rather than the absorption 
of allergen by epidermal LC precursors (56), which in this con-
dition will probably not encounter foreign particles.
Interestingly, we showed that the intracellular pool of 
PAR2 was increased in the more differentiated layers of the 
E19.5 KO epidermis and colocalized with TSLP and hyper-
active KLK5 in the upper layers of the KO epidermis (28, 43). 
of KLK5 mRNA but could also be the result of the activation 
of PAR2 by other hyperactivated proteases, such as KLK14 
(52) and/or other signaling pathway induction.
Figure 7.  TSLP and proinflammatory molecules are induced by 
KLK5 in keratinocytes of NS patients. (A) Quantitative RT-PCR on cul-
tured primary keratinocytes reveals that TSLP is significantly overexpressed 
by fivefold in three NS patients (NSK) compared with three healthy con-
trols (NHK). ICAM1, IL8, TNF-, TARC, and MDC mRNA are overexpressed in 
two out of three NSKs but not IL-1 mRNA. Each point represents the 
mean of two independent experiments for each individual. *, P < 0.05.  
(B) NHK and NSK were treated with 10 µg/ml brefeldin A, and TSLP was 
detected by immunofluorescence (green). Blue staining is DAPI. Pictures 
are representative of two independent brefeldin A treatments, each real-
ized on two NHKs and two NSKs. (C and D) NSKs were transfected with 
KLK5 siRNA and its efficient down-regulation was confirmed by quantita-
tive RT-PCR, Western blotting (laminin 5 used as loading control), and 
ELISA, 48 and 72 h after transfection. Results are representative of three 
independent experiments. (E) KLK5 knockdown induces a decrease of TSLP 
measured by quantitative RT-PCR. ICAM1, IL8, and TNF- mRNAs were less 
efficiently reduced. Data are the mean ± SD of one experiment, which is 
representative of three independent experiments. Bars, 49 µmJEM VOL. 206, May 11, 2009 
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worsening of the cutaneous phenotype observed in LEKTI-
deficient adult skin.
The Spink5/ skin grafts exhibit a marked inflammatory 
infiltrate in the absence of T cell–mediated immunity. This 
inflammatory infiltrate was essentially composed of polynu-
clear eosinophilic cells and activated mast cells that are usually 
present in allergic response. Interestingly, these features were 
associated neither with infection nor with the presence of 
mature T cells, as skin grafts were performed on athymic 
nude mice. It is of interest to note that elimination of T lym-
phocytes in K5-Tslp mice by crossing with TCR-–deficient 
mice does not affect eosinophilic and mast cell skin infiltra-
tion (21), as observed in Spink5 KO grafted skin. These data 
support the notion that, in our model, TSLP-mediated skin 
inflammation mainly involves the innate immune system and 
that this cytokine may directly recruit and activate mast cells 
that express TSLP receptor (59). TSLP, synergistically with 
IL-1 and TNF-, stimulates the production of pro-Th2   
cytokines by activated mast cells (59). Massive production of 
active 1-tryptase by activated mast cells in Spink5/ grafted 
skin could also directly participate in the inflammatory   
response and favor a Th2-permissive microenvironment 
Therefore, these early events observed in utero confirmed 
that deregulated KLK5 in the upper GR layers initiates the 
proinflammatory response through PAR2 cleavage and TSLP 
production in vivo.
IL-1 was also increased in the epidermis of Spink5/ 
embryos in contrast to primary keratinocytes from NS patients 
in culture. Nonetheless, IL-1 overexpression in Spink5/ 
embryos epidermis is likely to be a consequence of SC detach-
ment that is already present before birth (17). IL-1 can be 
proteolytically activated by KLK7 (57), which is hyperacti-
vated in Spink5/ skin (32). Thus, this protease could partici-
pate in the inflammatory process in our model as observed in 
KLK7 transgenic mice (58).
These proinflammatory mediators already in place at a 
late developmental stage (E19.5) in the epidermis of KO em-
bryos could contribute to the amplification of the proallergic 
microenvironment. In a context of immunocompetent mice, 
TARC and MDC could lead to the recruitment of Th2 
CCR4+ cells at the site of inflammation (51). In addition, 
IL-1 and TNF- overexpression in Spink5/ epidermis 
may induce TSLP expression in keratinocytes (19, 54) and 
attract innate immune cells. These processes could explain 
Figure 8.  KLK5 triggers proinflammatory and proallergic microenvironment independently of external stimuli. Lack of KLK5 inhibition by LEKTI 
initiates proinflammatory and proallergic cascades independently of environmental factors. In LEKTI-deficient keratinocytes, hyperactive KLK5 directly 
induces TSLP, IL8, and TNF- overexpression through PAR2 and NF-B pathway activation. Unregulated KLK5 also degrades desmosomes at the interface 
between the GR and the SC leading to defective SC adhesion and IL-1, IL8, and TNF- secretion by mechanically stressed keratinocytes. In addition, all 
these cytokines could induce TARC and MDC chemokines secretion by keratinocytes and dermal fibroblasts. These proinflammatory mediators trigger 
eosinophilic and mast cell recruitment and activation. TSLP has been reported to activate resident LCs, which migrate to draining lymph nodes and pro-
mote the differentiation of naive T cells (Th0) into Th2 cells. Collectively, activated keratinocytes together with eosinophilic and mast cells induce pro-Th2 
microenvironment favoring the development of an AD-like phenotype.1144 KLK5 MEDIATES AD VIA EPIDERMAL TSLP EXPRESSION IN NS | Briot et al.
jury. This new physiological pathway could also explain why 
the eczematous skin lesions in infants often start in the absence 
of specific IgE antibodies, indicating that IgE sensitization 
may occur secondary to eczema. This new mechanism, which 
is based on the control of epidermal serine protease activity, 
could be considered to be additional genetic regulation in-
volved in AD.
MATERIALS AND METHODS
Skin sample and dermis/epidermis separation technique. This work 
was approved by the Commission de Génie Génétique (23 November 2003, 
agreement number 3987) and by the Local Ethical Committee (DEC 04005). 
All experiments were done in accordance with the relevant guidelines and 
regulations. Mice embryos were delivered by caesarean at E19.5.
For RNA analysis, dermis/epidermis separation was performed by incu-
bating total dorsal skin into phosphate buffer saline containing 2.4 mg/ml 
dispase II (Roche) overnight at 4°C. For protein analysis, skin was incubated 
in PBS at 56°C for 45 min.
Skin grafting. Total dorsal skin from E19.5 mice was transplanted onto 
nude mice using the skin flap technique (67) and analyzed after 8 wk.
Histological and immunohistochemical analysis. Skin samples were 
fixed in 10% formalin and embedded in paraffin or directly frozen at 80°C 
in Tissue-Tek O.C.T. (Sakura). 4-µm sagittal sections were stained with 
hematoxylin/eosin or Toluidine blue for histological examination.
For antigen retrieval, paraffin-embedded cross sections were boiled in   
1 mM of citrate buffer, pH 6, for 20 min or treated with S1700 solution 
(Dako) for 45 min for Desmoglein-1 immunodetection. Skin cryosections 
were fixed with acetone for 10 min. Immunodetection was performed using 
appropriate  horseradish  peroxidase  (HRP;  diaminobenzidine)–conjugated 
polymers (EnVision system; Dako) or Alexa Fluor 488–coupled secondary 
antibody (Invitrogen).
Each NS patient was a homozygote or a compound heterozygote for 
SPINK5 mutations, leading to the absence of detectable LEKTI on immuno-
histochemical analysis of skin sections as previously described (27). Informed 
consent was obtained from the patients. This study was approved by the 
medical ethical committee of the Purpan Hospital in Toulouse. The study 
was conducted in compliance with the ethical principles of the Declaration 
of Helsinki.
Transmission electron microscopy analysis. WT and Spink5/ grafted 
skin samples were prepared as described previously (32).
Western blotting. Epidermises were crushed in protein extraction buffer 
(150 mM NaCl, 50 mM Tris HCl, pH 8, 5 mM EDTA, pH 8, 0.1% Non-
idet-P40, and protease inhibitor cocktail tablets [Complete; Roche]) with 
Ultra-Turrax. Equal amounts of soluble protein were added to Laemmli buffer 
(62.5 mM Tris HCl, pH 6.8, 5% -mercaptoethanol, 2% SDS, 10% glycerol, 
and 0.002% bromophenol blue). Samples were separated by SDS-PAGE and 
transferred onto Hybond-C extra membrane (GE Healthcare). For mouse 
1-tryptase detection, samples in acetic acid buffer were used. Total amount 
of protein was quantified by Bradford assay before gel migration and then by 
coomassie blue staining of SDS-PAGE gel and measurement of the intensity 
of every band with Image software (version 1.63; National Institutes of 
Health; Fig. S2). To quantify secreted KLK5 and Laminin 5, 20 µl of kerati-
nocyte conditioned medium was used.
Quantitative real-time PCR. Total RNA from mouse dermis and epi-
dermis and human keratinocytes, were isolated using the RNeasy mini kit 
(QIAGEN). Complementary DNA synthesis from 2–3 µg of total RNA was 
performed using SuperScript III First-Strand Synthesis system (Invitrogen).
Quantitative real-time PCR was realized on an ABI prism 7000 Sequence 
Detection system (Applied Biosystems) using qPCR MasterMix Plus SYBR 
through PAR2 activation on mast cells (60), dendritic cells 
(61), and eosinophils (62, 63). In addition, in an immune-
competent system, TSLP has the potential to activate den-
dritic cells and epidermal LCs in particular, triggering the 
generation of proallergic CD4+ Th2 cells (19, 20, 64).
Our present results established that Spink5/ epidermis 
by itself induces a cutaneous inflammatory response and the 
synthesis of proallergic mediators. This new mechanism could 
account for atopic manifestations in NS patients and is concor-
dant with TSLP overproduction in the epidermis of NS 
patients (Fig. 5) who display KLK5 and PAR2 deregulation 
(43). Thus, TSLP provides an important link between the ab-
sence of LEKTI protease inhibitor and the AD-like phenotype 
constantly seen in NS patients. This notion supports the possi-
bility that SPINK5 could play a role in atopic disease. Several 
studies have reported significant genetic association of SPINK5 
polymorphisms  with  AD  in  different  populations  (34–38), 
whereas other studies did not confirm these results (39–41). 
This suggests that SPINK5 genetic variations may account, to 
some extent, for predisposition to AD in some patients, de-
pending on other genetic and/or environmental factors.
Therefore,  expression  of  TSLP,  TARC,  and  MDC  by 
LEKTI-deficient keratinocytes could initiate and amplify the 
skin atopic inflammation as well as the systemic allergic re-
sponse of NS patients. The abundant and epidermally restricted 
TSLP secretion could induce an AD-like phenotype associated 
with elevated serum levels of IgE, as illustrated in Tslp skin-
specific transgenic mice (21, 65). Thereby, the effect of LEKTI 
deficiency on triggering PAR2 signaling could be a primary 
event inducing atopic manifestations in NS before skin barrier 
defect. In parallel, as the result of protease hyperactivities, FIL-
AGGRIN is also decreased (agranulosis) and the SC is often 
detached from the underlying cell layers in the epidermis of NS 
patients (43). Both anomalies impair skin barrier and favor al-
lergen and pathogen penetration in NS epidermis, thus con-
tributing to the aggravation of the atopic phenotype.
These results identify KLK5 as a major actor in NS be-
cause up-regulation of this protease has a direct effect on pro-
inflammatory signaling and on skin barrier disruption, both 
of which contribute to the development of atopic manifesta-
tions in NS. KLK5 and all the highlighted actors in this study 
constitute attractive candidates for therapeutic intervention, 
which are upstream from the IgE response and independent 
of allergen exposure. These new approaches based on block-
ing this biological cascade initiated in the epidermis could 
improve not only the allergic manifestations but also the skin 
barrier defect of NS patients. In addition, the results point 
out the importance of the control of protease/protease in-
hibitor balance in skin barrier function and in immune re-
sponse orientation.
An emerging hypothesis regarding asthma and AD is that 
they  are  epithelial  diseases  initiated  by  the  epithelial  cells 
themselves through the production of TSLP (66). In the pres-
ent study, we have identified a mechanism leading to the pro-
duction of the major pro-Th2 cytokine TSLP by skin epithelial 
cells, despite the absence of microbe products or physical in-JEM VOL. 206, May 11, 2009 
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Green I kit (Eurogentec). Results were normalized with the HPRT (human or 
mouse) gene and analyzed using Sequence Detection System version 1.2 (Ap-
plied Biosystems). P-values were calculated using the Student-Fischer test.
Human keratinocyte culture and siRNA transfection. NHKs were 
seeded on 6-well plates and grown in half EpiLife 0.06 mM CaCl2 (Invitro-
gen) and half Green medium (68) until confluency. NHK were treated with 
400 nM KLK5 (1 U trypsin-like equivalent) in serum-free Green medium 
for 3 h. For the NF-B pathway inhibition test, cells were treated 1 h before 
activation with 10 µM (E) 3-[(4-methylphenyl) sulfonyl]-2-propenenitrile 
(BAY11-7082; EMD). For siRNA transfection, NHK or primary keratino-
cytes from NS patients (NSK) were grown until 60% confluency. Cells were 
transfected with 60 pmol of human PAR2 siRNA or 20 pmol of human 
KLK5 siRNA (Santa Cruz Biotechnology, Inc.) using the transfection re-
agent jetSI-ENDO (Ozyme) in serum-free and antibiotic-free EpiLife. Con-
trol siRNA fluorescein conjugate (Santa Cruz Biotechnology, Inc.) was used 
as described by the manufacturer. 5 d after human PAR2 siRNA transfec-
tion, NHKs were treated with KLK5.
Immunocytofluorescence. NHK and NSK were seeded on 400-mm2 
slides. Cells were incubated with 10 µg/ml brefeldin A (eBioscience) for 3 h, 
fixed in 4% formaldehyde solution, and incubated overnight with human 
TSLP antibody at 4°C. Signal was detected with an FITC-conjugated sec-
ondary antibody (Dako) and nuclei were stained with DAPI (Vector Labo-
ratories). Fluorescence signal was visualized with an inverted high-end 
microscope (Axiovert 200; Carl Zeiss, Inc.).
Immunofluorometric assay (ELISA) for human KLK5. MaxiSorp 96-
well plates (Thermo Fisher Scientific) were coated with 1 µg per well of Fc 
fragment–specific goat polyclonal anti–mouse IgG (Interchim). Saturation 
was performed with a solution containing 5% BSA and 5% sucrose. Mouse 
monoclonal anti-human KLK5 antibody (R&D systems) in 1% BSA, 0.05% 
Tween 20, and PBS was added to each well and incubated overnight at 4°C. 
50 µl of undiluted or diluted cell-conditioned medium were incubated for 2 h 
at room temperature. KLK5 detection was performed using a biotinylated 
polyclonal goat anti–human KLK5 antibody (BAF1108; R&D systems). Sig-
nal was revealed using HRP-coupled streptavidin (N-100; Endogen; Inter-
chim) and UptiLight HS ELISA HRP substrate (Interchim). Luminescence 
was recorded with Mithras (Berthold Technologies). Recombinant human 
KLK5 (R&D system) was used as standard range.
Online supplemental material. Table S1 provides information about 
primary antibodies and control antibodies used. Table S2 indicates primer 
sequences for mouse and human complementary DNA PCR amplifica-
tion. Fig. S1 is a graphic representation of the increased number of eosino-
philic and mast cells in the dermis of KO grafted skin. Fig. S2 shows a 
loading control for 1-tryptase Western blotting, 1-tryptase hyperactiv-
ity, and its inhibition by leupeptin in KO grafted skin by casein gel zymog-
raphy. Fig. S3 shows increased expression of ICAM1 protein in E19.5 KO 
epidermis by Western blot analysis. Fig. S4 confirms by immunocytofluo-
rescence that KLK5 treatment induces TSLP protein expression in NHK. 
Fig. S5 shows negative staining with rabbit and goat control antibodies on 
mouse skin sections. Fig. S6 shows negative staining with mouse isotype 
control and rabbit control antibody on human skin sections and cultured 
keratinocytes. A supplemental materials and methods is also provided for 
the casein gel zymography experiment. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20082242/DC1.
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